November 4, 2024
How immunotherapy innovation has grown at Ohio State
Immunotherapy innovation is a full-time focus at an Ohio State institute where researchers develop new ways to treat cancer with patients’ own natural defenses.
OSUCCC – James Blog
Showing 1-10 of 14
July 20, 2022
How new research could lead to breakthroughs in the treatment of aggressive brain cancers
Aggressive tumors require relentless research, which is why Ohio State brain cancer specialists work every day to break new ground in glioblastoma treatment.
May 19, 2022
Learn about glioblastoma, the most commonly-diagnosed brain cancer
While glioblastomas are difficult to treat, comprehensive treatment plans provide patients with the best therapies for the disease.
March 24, 2021
'A Source of Hope': President Biden Touts Support for Cancer Doctors, Researchers During Ohio State Visit
President Joe Biden brought his passion for cancer research to Ohio State, where he met with doctors to discuss innovation underway at The James.
August 22, 2019
Ohio State Clinical Trial Uses New Drug to Target Cancer Cells
By targeting a specific protein, Ohio State researchers hope to provide more effective treatments for patients with hard-to-cure cancers.
December 19, 2016
Cold Virus: A New Brain Cancer Treatment Option?
After decades of fighting cancer on its own terms, oncologists are using viruses as the core of experimental treatments to attack brain cancer.
March 23, 2016
OSUCCC – James Radiation Oncology: One of the World’s Premier Programs
The Department of Radiation Oncology at The James offers innovation in research, comfortable environment for patients.
March 15, 2016
Ohio State Researcher's Work Named 'Key Breakthrough' in Cancer by American Cancer Society
Dr. Deliang Guo's research focuses on glioblastomas, which are brain tumors that are very resistant to treatment. His research was recently recognized by the American Cancer Society.
November 20, 2015
Drug Development Institute & Pelotonia: Advancing Development of Novel Anticancer Drugs
The Drug Development Institute (DDI) was founded in 2011 to guide the development of promising anticancer drugs produced by OSUCCC - James researchers.
October 16, 2015
Cancer Researcher 'Always Learning' Through Laboratory Studies
Balveen Kaur, PhD, a professor in the Department of Neurological Surgery at Ohio State, embraces her roles as both teacher and learner.